AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DESMOPRESSINE

11 registrations across 3 African markets— 4 active

Markets with DESMOPRESSINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
MINIRIN
Lyophilisat oral / 60 µg
🇹🇳TunisiaFERRING GmbHexpiredJun 2018
MINIRIN
Solution injectable / 4 µg/ml
🇹🇳TunisiaFERRING GmbHexpiredMar 2018
MINIRIN
Lyophilisat oral / 120 µg
🇹🇳TunisiaFERRING GmbHexpiredNov 2016
MINIRINMELT
Lyophilisat oral / 60 µg
🇹🇳TunisiaFERRING S.A.SexpiredAug 2010
MINIRIN
Solution injectable / 4 µG
🇹🇳TunisiaFERRING S.A.SexpiredMar 1995
MINIRIN
Spray nasal / 10 µG
🇹🇳TunisiaFERRING S.A.SexpiredMar 1995
MINIRIN
Solution pour administration endonasale / 0.1 mg
🇹🇳TunisiaFERRING S.A.SexpiredMay 1994
MINIRIN
COMPRIME
🇲🇦Moroccoactive
MINIRINMELT
lyophilisat / 120 mcg
🇸🇳SenegalFERRING S.A.S.active
MINIRIN SPRAY
SOLUTION ENDONASALE
🇲🇦Moroccoactive
MINIRINMELT
lyophylisat / 60 mcg
🇸🇳SenegalFERRING S.A.S.active

DESMOPRESSINE in Africa — Regulatory Overview

DESMOPRESSINE is registered across 3 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 4 (36%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.